Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 2
1967 1
1970 1
1973 2
1974 1
1975 1
1977 2
1978 1
1980 3
1981 1
1983 1
1984 1
1985 1
1986 2
1987 1
1988 4
1990 3
1991 6
1992 2
1993 2
1994 7
1995 2
1996 2
1997 2
1998 3
1999 4
2000 3
2001 11
2002 6
2003 3
2004 12
2005 14
2006 8
2007 8
2008 13
2009 6
2010 18
2011 11
2012 15
2013 13
2014 24
2015 13
2016 9
2017 12
2018 18
2019 16
2020 19
2021 12
2022 22
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

329 results

Results by year

Filters applied: . Clear all
Page 1
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups. Hauser SL, et al. N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246. N Engl J Med. 2020. PMID: 32757523 Clinical Trial.
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Global Alliance for the Promotion of Physical Activity: the Hamburg Declaration.
Steinacker JM, van Mechelen W, Bloch W, Börjesson M, Casasco M, Wolfarth B, Knoke C, Papadopoulou T, Wendt J, Al Tunaiji H, Andresen D, Andrieieva O, Bachl N, Badtieva V, Beucher FJ, Blauwet CA, Casajus Mallen JA, Chang JH, Clénin G, Constantini N, Constantinou D, Di Luigi L, Declercq L, Doutreleau S, Drozdovska S, Duclos M, Ermolao A, Fischbach T, Fischer AN, Fossati C, Franchella J, Fulcher M, Galle JC, Gerloff C, Georgiades E, Gojanovic B, González Gross M, Grote A, Halle M, Hauner H, Herring MP, Hiura M, Holze K, Huber G, Hughes D, Hutchinson MR, Ionescu A, Janse van Rensburg DC, Jegier A, Jones N, Kappert-Gonther K, Kellerer M, Kimura Y, Kiopa A, Kladny B, Koch G, Kolle E, Kolt G, Koutedakis Y, Kress S, Kriemler S, Kröger J, Kuhn C, Laszlo R, Lehnert R, Lhuissier FJ, Lüdtke K, Makita S, Manonelles Marqueta P, März W, Micallef-Stafrace K, Miller M, Moore M, Müller E, Neunhäuserer D, Onur IR, Ööpik V, Perl M, Philippou A, Predel HG, Racinais S, Raslanas A, Reer R, Reinhardt K, Reinsberger C, Rozenstoka S, Sallis R, Sardinha LB, Scherer M, Schipperijn J, Seil R, Tan B, Schmidt-Trucksäss A, Schumacher N, Schwaab B, Schwirtz A, Suzuki M, Swart J, Tiesler R, Tippelt U, Tille… See abstract for full author list ➔ Steinacker JM, et al. Among authors: wendt j. BMJ Open Sport Exerc Med. 2023 Jul 27;9(3):e001626. doi: 10.1136/bmjsem-2023-001626. eCollection 2023. BMJ Open Sport Exerc Med. 2023. PMID: 37533594 Free PMC article.
Sugar-sweetened beverage tax implementation processes: results of a scoping review.
Forberger S, Reisch L, Meshkovska B, Lobczowska K, Scheller DA, Wendt J, Christianson L, Frense J, Steinacker JM, Luszczynska A, Zeeb H; PEN Consortium. Forberger S, et al. Among authors: wendt j. Health Res Policy Syst. 2022 Mar 24;20(1):33. doi: 10.1186/s12961-022-00832-3. Health Res Policy Syst. 2022. PMID: 35331245 Free PMC article. Review.
ENIGMA-anxiety working group: Rationale for and organization of large-scale neuroimaging studies of anxiety disorders.
Bas-Hoogendam JM, Groenewold NA, Aghajani M, Freitag GF, Harrewijn A, Hilbert K, Jahanshad N, Thomopoulos SI, Thompson PM, Veltman DJ, Winkler AM, Lueken U, Pine DS, van der Wee NJA, Stein DJ; ENIGMA-Anxiety Working Group. Bas-Hoogendam JM, et al. Hum Brain Mapp. 2022 Jan;43(1):83-112. doi: 10.1002/hbm.25100. Epub 2020 Jul 3. Hum Brain Mapp. 2022. PMID: 32618421 Free PMC article. Review.
Frameworks for implementation of policies promoting healthy nutrition and physically active lifestyle: systematic review.
Lobczowska K, Banik A, Romaniuk P, Forberger S, Kubiak T, Meshkovska B, Neumann-Podczaska A, Kaczmarek K, Scheidmeir M, Wendt J, Scheller DA, Wieczorowska-Tobis K, Steinacker JM, Zeeb H, Luszczynska A. Lobczowska K, et al. Among authors: wendt j. Int J Behav Nutr Phys Act. 2022 Feb 12;19(1):16. doi: 10.1186/s12966-021-01242-4. Int J Behav Nutr Phys Act. 2022. PMID: 35151330 Free PMC article. Review.
Lipoatrophia semicircularis - a distinct entity?
Sigl J, Lázár M, Tittes J, Wendt J, Kancz S, Kiefer FW, Valencak J, Okamoto I, Lichtenberger BM, Handisurya A. Sigl J, et al. Among authors: wendt j. Int J Dermatol. 2020 Nov;59(11):e385-e387. doi: 10.1111/ijd.15138. Epub 2020 Aug 17. Int J Dermatol. 2020. PMID: 32808284 No abstract available.
329 results